Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:09:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:36:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' condition label and the related topics section, including the 'MedlinePlus Genetics' link.
    Difference
    0.1%
    Check dated 2026-02-25T20:09:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added core topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page to Revision v3.4.2. Removed the government-funding lapse notice and the previous revision tag v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T12:34:33.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Notice about lapse in government funding and a version revision were added, while a non-critical topic (“Multiple myeloma”) was removed from related content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:57:37.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The author list for the DREAMM-2 publication has been removed. The page now includes a Show glossary option and new update metadata such as Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:25:50.000Z thumbnail image

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.